Company Overview and News

 
The Zacks Analyst Blog Highlights: IBM, United Continental, Lam Research, CSX and Intuitive Surgical

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include IBM Corp. (IBM - Free Report) , United Continental (UAL - Free Report) , Lam Research (LRCX - Free Report) , CSX Corp. (CSX - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Upvote Downvote

 
Zacks Investment Ideas feature highlights: Fiat Chrysler, Volkswagen AG, Dana and Douglas Dynamics

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Today, Zacks Investment Ideas feature highlights Features: Fiat Chrysler (FCAU - Free Report) , Volkswagen AG (VLKAY - Free Report) , Dana Incorporated (DAN - Free Report) and Douglas Dynamics (PLOW - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: AbbVie, Berkshire Hathaway, PepsiCo, BP and Twenty-First Century Fox

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include AbbVie (ABBV - Free Report) , Berkshire Hathaway (BRK.B - Free Report) , PepsiCo (PEP - Free Report) , BP (BP - Free Report) and Twenty-First Century Fox (FOXA - Free Report) .
Upvote Downvote

1
Zacks Investment Ideas feature highlights: Spotify, Apple, Amazon and Pandora

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Today, Zacks Investment Ideas feature highlights Features: Spotify (SPOT - Free Report) , Apple (AAPL - Free Report) , Amazon (AMZN - Free Report) and Pandora (P - Free Report) .
Upvote Downvote

 
Zacks.com highlights: Western Digital, ArcelorMittal, Arrow Electronics and Horizon Pharma Public

2018-04-18 zacks
Chicago, IL – April 18, 2018 - Stocks in this week’s article include: Western Digital Corporation (WDC - Free Report) , ArcelorMittal (MT - Free Report) , Arrow Electronics, Inc. (ARW - Free Report) and Horizon Pharma Public Limited Company (HZNP - Free Report) .
Upvote Downvote

 
Zacks Industry Outlook Highlights: SPDR S&P Insurance, National General Holdings, Kinsale Capital Group, Aegon N.V. and Health Insurance Innovations

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Today, Zacks Equity Research discusses the Industry: Insurance, Part 1, including SPDR S&P Insurance ETF (KIE - Free Report) , National General Holdings Corp. (NGHC - Free Report) , Kinsale Capital Group, Inc. (KNSL - Free Report) , Aegon N.V. (AEG - Free Report) and Health Insurance Innovations, Inc. (HIIQ - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: salesforce.com, DXC Technology, Equity Bancshares, Myers Industries and Harsco

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include salesforce.com, inc. (CRM - Free Report) , DXC Technology Company (DXC - Free Report) , Equity Bancshares, Inc. (EQBK - Free Report) , Myers Industries, Inc.
Upvote Downvote

 
Zacks.com highlights: EMCOR Group, CBRE Group, Arrow Electronics, Steel Dynamics and CMS Energy

2018-04-18 zacks
Chicago, IL – April 18, 2018 - Stocks in this week’s article include: EMCOR Group, Inc. (EME - Free Report) , CBRE Group, Inc. (CBRE - Free Report) , Arrow Electronics, Inc. (ARW - Free Report) , Steel Dynamics, Inc. (STLD - Free Report) and CMS Energy Corporation (CMS - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: VanEck Vectors Semiconductor, iShares PHLX Semiconductor, PowerShares Dynamic Semiconductor, SPDR S&P Semiconductor and First Trust Nasdaq Semiconductor

2018-04-18 zacks
Chicago, IL – April 18, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include VanEck Vectors Semiconductor ETF (SMH - Free Report) , iShares PHLX Semiconductor ETF (SOXX - Free Report) , PowerShares Dynamic Semiconductor (PSI - Free Report) , SPDR S&P Semiconductor ETF (XSD - Free Report) and First Trust Nasdaq Semiconductor ETF (FTXL - Free Report) .
Upvote Downvote

 
Zacks Industry Outlook Highlights: Jinko Solar, Azure Power Global, Dominion Midstream, SunPower and NextEra Energy Partners

2018-04-17 zacks
Chicago, IL – April 17, 2018 – Today, Zacks Equity Research discusses the Industry: Alternative Energy, Part 3, including Jinko Solar (JKS - Free Report) , Azure Power Global (AZRE - Free Report) , Dominion Midstream (DM - Free Report) , SunPower Corp (SPWR - Free Report) and NextEra Energy Partners (NEP - Free Report) .
Upvote Downvote

 
Will Solar Import Tariffs Hurt U.S. Alternative Energy?

2018-04-16 zacks
China’s emergence as a global leader of investment in clean energy projects poses serious threat to U.S based operators for the Alternative Energy industry. China has been a frontrunner in terms of solar module manufacturing and it has made substantial wind power investments in 2017 to expand its renewables footprint worldwide.
Upvote Downvote

 
NextEra Energy Partners: Dividend Growth To Continue Despite Canadian Portfolio Sale

2018-04-06 seekingalpha
NextEra Energy Partners (NYSE:NEP) is a leading renewable YieldCo. The company has recently announced the sale of its 396MW Canadian portfolio to Canada Pension Plan Investment Board. The company had previously announced it was considering a sale of its Canadian assets, and to re-invest sale proceeds into its development pipeline.
Upvote Downvote

 
NextEra Energy Partners to Sell Canadian Assets for $582M

2018-04-03 zacks
NextEra Energy Partners (NEP - Free Report) announced that it has entered into a definite agreement with Canada Pension Plan Investment Board (“CPPIB”) to sell its renewable assets situated in Ontario, Canada for $582.3 million. Per the deal, the buyer will also assume NextEra Energy Partners’ existing debt of $689 million. NextEra Energy Partners expects that the sale of Canadian renewable portfolio will be over by second-quarter 2018, subject to customary closing conditions.
Upvote Downvote

 
NextEra to sell Canadian wind and solar assets to CPPIB

2018-04-02 reuters
(Reuters) - U.S. utility NextEra Energy Partners (NEP.N) said on Monday it would sell its wind and solar assets in Ontario to Canada Pension Plan Investment Board (CPPIB) for about $582.3 million.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 65341B106